The study found the candidate elicits “robust antibody responses” and is well-tolerated, the company said Tuesday.
Image: Novavax is advancing a Covid-19 vaccine candidate through clinical trials. COURTESY NOVAVAX
SUBSCRIBE
Biohealth Innovation
Founding Member of
